Filtering by:
Cervical CancerCervical Precancers Drop Since Introduction of HPV Vaccine
A study using data from the Centers for Disease Control and Prevention (CDC) provides evidence that the human papillomavirus (HPV) vaccine is effectively reducing the numbers of cervical precancer – lesions that can become cervical cancer.
Who Should Get the HPV Vaccination and Why
The HPV vaccine can protect people from getting the types of HPV infections that cause 6 different kinds of cancer. The vaccinations work best when given to people when they’re young.
What You Need to Know About Testing for Cervical Cancer
During the past several decades, screening – testing for cancer before symptoms develop – has reduced deaths from cervical cancer, as doctors have been able to find cancer early and treat it, or prevent it from developing.
Year in Review: Cancer Research Insights from 2018
Read highlights about American Cancer Society research from 2018.
3-Time Cancer Survivor Finds Comfort at Hope Lodge
Cervical and breast cancer survivor Christine E. Sprecher needed treatment for a long-term side effect but had no place to stay until she found the American Cancer Society Hope Lodge program.
Studies Find Open Surgery Safer For Early Cervical Cancer
Researchers at the University of Texas MD Anderson Cancer Center and colleagues find that women who undergo minimally invasive radical hysterectomy to treat early-stage cervical cancer have worse outcomes than women who undergo abdominal “open” radical hysterectomy.
The HPV Vaccine: A Powerful Way to Help Prevent 3+ Cancers in Women
World HPV Infection Expert, Anna Guiliano, PhD, says, we may be able to eliminate cervical cancer in the U.S. because we have effective screening tests and guidelines for how often they need to be done, as well as vaccines to prevent the infections that cause damage, called lesions, to cells in the cervix. She offers reminders and tips to parents and adult women and men about how they can protect themselves from all cancers related to HPV.
A World Leader in Infection-Related Cancer Research
Anna Giuliano, PhD, an epidemiology professor and researcher at the Moffitt Cancer Center in Tampa, Florida was awarded the prestigious American Cancer Society Research Professor grant in July 2018 for her expertise and ongoing work cancers caused by the human papillomavirus (HPV).
